Cheng Ming-Fu, Hung Ming-Shiu, Song Jen-Shin, Lin Shu-Yu, Liao Fang-Yu, Wu Mine-Hsine, Hsiao Wenchi, Hsieh Chia-Ling, Wu Jian-Sung, Chao Yu-Sheng, Shih Chuan, Wu Su-Ying, Ueng Shau-Hua
Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli County 35053, Taiwan, ROC.
Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli County 35053, Taiwan, ROC.
Bioorg Med Chem Lett. 2014 Aug 1;24(15):3403-6. doi: 10.1016/j.bmcl.2014.05.084. Epub 2014 Jun 4.
A novel class of phenyl benzenesulfonylhydrazides has been identified as potent inhibitors of indoleamine 2,3-dioxygenase (IDO), and their structure-activity relationship was explored. Coupling reactions between various benzenesulfonyl chlorides and phenylhydrazides were utilized to synthesize the sulfonylhydrazides bearing various substituents. Compound 3i exhibited 61 nM of IC50 in enzymatic assay and 172 nM of EC50 in the HeLa cell. The computational study of 3i suggested that the major interactions between 3i and IDO protein are the coordination of sulfone and heme iron, the hydrogen bonding and hydrophobic interactions between 3i and IDO. This novel class of IDO inhibitor provides a new direction to discover effective anti-cancer agents.
一类新型的苯基苯磺酰肼已被鉴定为吲哚胺2,3-双加氧酶(IDO)的强效抑制剂,并对其构效关系进行了探索。利用各种苯磺酰氯与苯肼之间的偶联反应合成了带有各种取代基的磺酰肼。化合物3i在酶促试验中表现出61 nM的IC50,在HeLa细胞中表现出172 nM的EC50。对3i的计算研究表明,3i与IDO蛋白之间的主要相互作用是砜与血红素铁的配位、3i与IDO之间的氢键和疏水相互作用。这类新型的IDO抑制剂为发现有效的抗癌药物提供了新的方向。